Article

In the pipeline: B&L, InSite to develop compound for infections

San Dimas, CA-Bausch & Lomb and InSite Vision will develop a fourth-generation fluoroquinolone that incorporates InSite Vision's drug delivery system, DuraSite.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.